Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.
Conventional magnetic resonance imaging (MRI) at 1.5 Tesla (T) is limited by modest spatial resolution and signal-to-noise ratio (SNR), impeding the identification and classification of inflammatory central nervous system changes in current clinical practice. Gaining from enhanced susceptibility effects and improved SNR, ultrahigh field MRI at 7 T depicts inflammatory brain lesions in great detail. This review summarises recent reports on 7 T MRI in neuroinflammatory diseases and addresses the question as to whether ultrahigh field MRI may eventually improve clinical decision-making and personalised disease management.
['Sinnecker|Tim|T|', 'Kuchling|Joseph|J|', 'Dusek|Petr|P|', 'Dörr|Jan|J|', 'Niendorf|Thoralf|T|', 'Paul|Friedemann|F|', 'Wuerfel|Jens|J|']
Ultrahigh field MRI Neuroimmunology 7 Tesla Central vein sign Cortical lesions Multiple sclerosis Neuromyelitis optica Predictive, Preventive and Personalised Medicine Susac syndrome